ACB
CRNC icon

Aristotle Capital Boston’s Cerence CRNC Stock Holding History

Aristotle Capital Boston’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-625,952
Closed -$9.86M – 128
2024
Q1 		$9.86M Buy
625,952
+40,440
+7% +$684K 0.3% 107
2023
Q4 		$11.5M Buy
585,512
+118,092
+25% +$2.05M 0.35% 101
2023
Q3 		$9.52M Buy
467,420
+374,836
+405% +$9.42M 0.31% 109
2023
Q2 		$2.71M Buy
+92,584
New +$2.54M 0.08% 131

Other funds holding CRNC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Boston's CRNC Position: Q2 2024 in Review

Aristotle Capital Boston sold out of Cerence (CRNC) in Q2 2024, closing a stake of 625,952 shares — an estimated $9.86M sold.

Aristotle Capital Boston first reported a position in CRNC in Q2 2023 and held it in 4 quarters. The position peaked at $11.5M in Q4 2023. 186 funds tracked by Wall St. Rank hold CRNC as of Q2 2024.

  • Aristotle Capital Boston reported no remaining Cerence position as of Q2 2024 after selling out during the quarter.
  • Aristotle Capital Boston sold 625,952 Cerence shares in Q2 2024, an estimated $9.86M.
  • Aristotle Capital Boston first reported a position in Cerence in Q2 2023 and held it in 4 quarters.
  • Aristotle Capital Boston's Cerence position peaked at $11.5M in Q4 2023.
  • 186 funds tracked by Wall St. Rank held Cerence as of Q2 2024.

Based on Aristotle Capital Boston's 13F filing for Q2 2024, filed 14 Aug 2024.